39 research outputs found

    Einsatz mobiler Hühnerställe in der Praxis – ein Vergleich von zwei Systemen

    Get PDF
    Der Anteil der Auslaufhaltungssysteme für Legehennen nimmt zu. Allerdings sind mobile Haltungssysteme noch nicht weit verbreitet. In Deutschland werden vor allem Mobilställe zweier Hersteller eingesetzt. Ein Hersteller setzt Folientunnel auf Stahlträgerkufen ein (Typ 1), der andere Ställe auf Rädern (Typ 2). Ziel der Untersuchung war eine aktuelle Befragung der Mobilstallbetreiber(Typ 1: 110 Betriebe, Typ 2: 134 Betriebe) durchzuführen. 61 Fragebögen von Legehennenhaltern und 12 Fragebögen von Masthühnerhaltern wurden ausgewertet. Betriebe mit Typ 1 hielten mehr Hühner und versetzten die Ställe weniger häufig. Die Hühner hatten im Vergleich zu Typ 2 weniger Auslauffläche. Betriebe mit Typ 2 erzielten höhere Eierpreise

    Efficacy of CMX001 as a Prophylactic and Presymptomatic Antiviral Agent in New Zealand White Rabbits Infected with Rabbitpox Virus, a Model for Orthopoxvirus Infections of Humans

    Get PDF
    CMX001, a lipophilic nucleotide analog formed by covalently linking 3-(hexdecyloxy)propan-1-ol to cidofovir (CDV), is being developed as a treatment for smallpox. CMX001 has dramatically increased potency versus CDV against all dsDNA viruses and, in contrast to CDV, is orally available and has shown no evidence of nephrotoxicity in healthy volunteers or severely ill transplant patients to date. Although smallpox has been eliminated from the environment, treatments are urgently being sought due to the risk of smallpox being used as a bioterrorism agent and for monkeypox virus, a zoonotic disease of Africa, and adverse reactions to smallpox virus vaccinations. In the absence of human cases of smallpox, new treatments must be tested for efficacy in animal models. Here we first review and discuss the rabbitpox virus (RPV) infection of New Zealand White rabbits as a model for smallpox to test the efficacy of CMX001 as a prophylactic and early disease antiviral. Our results should also be applicable to monkeypox virus infections and for treatment of adverse reactions to smallpox vaccination

    Development of CMX001 for the Treatment of Poxvirus Infections

    Get PDF
    CMX001 (phosphonic acid, [[(S)-2-(4-amino-2-oxo-1(2H)-pyrimidinyl)-1-(hydroxymethyl)ethoxy]methyl]mono[3-(hexadecyloxy)propyl] ester) is a lipid conjugate of the acyclic nucleotide phosphonate, cidofovir (CDV). CMX001 is currently in Phase II clinical trials for the prophylaxis of human cytomegalovirus infection and under development using the Animal Rule for smallpox infection. It has proven effective in reduction of morbidity and mortality in animal models of human smallpox, even after the onset of lesions and other clinical signs of disease. CMX001 and CDV are active against all five families of double-stranded DNA (dsDNA) viruses that cause human morbidity and mortality, including orthopoxviruses such as variola virus, the cause of human smallpox. However, the clinical utility of CDV is limited by the requirement for intravenous dosing and a high incidence of acute kidney toxicity. The risk of nephrotoxicity necessitates pre-hydration and probenecid administration in a health care facility, further complicating high volume CDV use in an emergency situation. Compared with CDV, CMX001 has a number of advantages for treatment of smallpox in an emergency including greater potency in vitro against all dsDNA viruses that cause human disease, a high genetic barrier to resistance, convenient oral administration as a tablet or liquid, and no evidence to date of nephrotoxicity in either animals or humans. The apparent lack of nephrotoxicity observed with CMX001 in vivo is because it is not a substrate for the human organic anion transporters that actively secrete CDV into kidney cells. The ability to test the safety and efficacy of CMX001 in patients with life-threatening dsDNA virus infections which share many basic traits with variola is a major advantage in the development of this antiviral for a smallpox indication

    The vertical variability of black carbon observed in the atmospheric boundary layer during DACCIWA

    Get PDF
    This study underlines the important role of the transported black carbon (BC) mass concentration in the West African monsoon (WAM) area. BC was measured with a micro-aethalometer integrated in the payload bay of the unmanned research aircraft ALADINA (Application of Light-weight Aircraft for Detecting IN situ Aerosol). As part of the DACCIWA (Dynamics–Aerosol–Chemistry–Cloud Interactions in West Africa) project, 53 measurement flights were carried out at Savè, Benin, on 2–16 July 2016. A high variability of BC (1.79 to 2.42±0.31 µg m−3) was calculated along 155 vertical profiles that were performed below cloud base in the atmospheric boundary layer (ABL). In contrast to initial expectations of primary emissions, the vertical distribution of BC was mainly influenced by the stratification of the ABL during the WAM season. The article focuses on an event (14 and 15 July 2016) which showed distinct layers of BC in the lowermost 900 m above ground level (a.g.l.). Low concentrations of NOx and CO were sampled at the Savè supersite near the aircraft measurements and suggested a marginal impact of local sources during the case study. The lack of primary BC emissions was verified by a comparison of the measured BC with the model COSMO-ART (Consortium for Small-scale Modelling–Aerosols and Reactive Trace gases) that was applied for the field campaign period. The modelled vertical profiles of BC led to the assumption that the measured BC was already altered, as the size was mainly dominated by the accumulation mode. Further, calculated vertical transects of wind speed and BC presume that the observed BC layer was transported from the south with maritime inflow but was mixed vertically after the onset of a nocturnal low-level jet at the measurement site. This report contributes to the scope of DACCIWA by linking airborne BC data with ground observations and a model, and it illustrates the importance of a more profound understanding of the interaction between BC and the ABL in the WAM region

    Springer Tracts in Advanced Robotics

    No full text
    Hitting and batting tasks, such as tennis forehands, ping-pong strokes, or baseball batting, depend on predictions where the ball can be intercepted and how it can properly be returned to the opponent. These predictions get more accurate over time, hence the behaviors need to be continuously modified. As a result, movement templates with a learned global shape need to be adapted during the execution so that the racket reaches a target position and velocity that will return the ball over to the other side of the net or court. It requires altering learned movements to hit a varying target with the necessary velocity at a specific instant in time. Such a task cannot be incorporated straightforwardly in most movement representations suitable for learning. For example, the standard formulation of the dynamical system based motor primitives (introduced by Ijspeert et al (2002b)) does not satisfy this property despite their flexibility which has allowed learning tasks ranging from locomotion to kendama. In order to fulfill this requirement, we reformulate the Ijspeert framework to incorporate the possibility of specifying a desired hitting point and a desired hitting velocity while maintaining all advantages of the original formulation.We show that the proposed movement template formulation works well in two scenarios, i.e., for hitting a ball on a string with a table tennis racket at a specified velocity and for returning balls launched by a ball gun successfully over the net using forehand movements

    First pharmacokinetic and safety study in humans of the novel lipid antiviral conjugate CMX001, a broadspectrum oral drug active against double-stranded DNA viruses. Antimicrob Agents Chemother

    No full text
    CMX001 is a novel, broad-spectrum lipid antiviral conjugate (LAC) that produces high intracellular levels of the active antiviral agent cidofovir diphosphate (CDV-PP). Study CMX001-102 was a randomized, double-blind, placebo-controlled, parallel group, dose-escalating study in healthy volunteers. The objectives of the study were to evaluate the safety and pharmacokinetic parameters of CMX001 after single and multiple doses. Single doses ranging from 0.25 to 2.0 mg/kg of body weight and multiple doses ranging from 0.1 to 1.0 mg/kg (3 total doses, administered every 6 days) were given orally. Safety was assessed using comprehensive clinical and laboratory evaluations, including enhanced monitoring for potential gastrointestinal (GI) effects using wireless capsule endoscopy (WCE). Serial plasma and pooled urine samples were collected to estimate pharmacokinetic parameters for both CMX001 and cidofovir (CDV). No adverse events occurred that prevented dose escalation. No clinically significant drugrelated changes in blood chemistry, hematology, renal function, or intraocular pressure were observed. No CMX001-related gastrointestinal mucosal changes were observed by WCE. CMX001 was absorbed rapidly, with maximum plasma concentrations observed 2 to 3 h postdose. Maximum plasma drug concentration and systemic exposure of CMX001 increased approximately in proportion to dose following single and multiple doses; no significant accumulation of CMX001 or CDV was observed following multiple doses. We conclude that CMX001 is orally bioavailable and well tolerated in healthy volunteers at doses up to 2 mg/kg, approximately 140 mg in a typical adult. This is the first demonstration of the use of phospholipid conjugation technology to achieve plasma drug exposures that are expected to result in activity against multiple double-stranded DNA viruses

    Movement Templates for Learning of Hitting and Batting

    No full text
    Abstract—Hitting and batting tasks, such as tennis forehands, ping-pong strokes, or baseball batting, depend on predictions where the ball can be intercepted and how it can properly be returned to the opponent. These predictions get more accurate over time, hence the behaviors need to be continuously modified. As a result, movement templates with a learned global shape need to be adapted during the execution so that the racket reaches a target position and velocity that will return the ball over to the other side of the net or court. It requires altering learned movements to hit a varying target with the necessary velocity at a specific instant in time. Such a task cannot be incorporated straightforwardly in most movement representations suitable for learning. For example, the standard formulation of the dynamical system based motor primitives (introduced by Ijspeert et al. [1]) does not satisfy this property despite their flexibility which has allowed learning tasks ranging from locomotion to kendama. In order to fulfill this requirement, we reformulate the Ijspeert framework to incorporate the possibility of specifying a desired hitting point and a desired hitting velocity while maintaining all advantages of the original formulation. We show that the proposed movement template formulation works well in two scenarios, i.e., for hitting a ball on a string with a table tennis racketataspecifiedvelocityandforreturningballslaunchedby a ball gun successfully over the net using forehand movements. All experiments were carried out on a Barrett WAM using a four camera vision system. I

    The association of immunosurveillance and distant metastases in colorectal cancer

    Get PDF
    BACKGROUND Colorectal cancer (CRC) is the third most common malignancy worldwide, but the key driver to distant metastases is still unknown. This study aimed to elucidate the link between immunosurveillance and organotropism of metastases in CRC by evaluating different gene signatures and pathways. MATERIAL AND METHODS CRC patients undergoing surgery at the Department of General, Visceral and Transplantation Surgery at the Ludwig-Maximilian University Hospital Munich (Munich, Germany) were screened and categorized into M0 (no distant metastases), HEP (liver metastases) and PER (peritoneal carcinomatosis) after a 5-year follow-up. Six patients of each group were randomly selected to conduct a NanoString analysis, which includes 770 genes. Subsequently, all genes were further analyzed by gene set enrichment analysis (GSEA) based on seven main cancer-associated databases. RESULTS Comparing HEP vs. M0, the gene set associated with the Toll-like receptor (TLR) cascade defined by the Reactome database was significantly overrepresented in HEP. HSP90B1, MAPKAPK3, PPP2CB, PPP2R1A were identified as the core enrichment genes. The immunologic signature pathway GSE6875_TCONV_VS_FOXP3_KO_TREG_DN with FOXP3 as downstream target was significantly overexpressed in M0. RB1, TMEM 100, CFP, ZKSCAN5, DDX50 were the core enrichment genes. Comparing PER vs. M0 no significantly differentially expressed gene signatures were identified. CONCLUSION Chronic inflammation might enhance local tumor growth. This is the first study identifying immune related gene sets differentially expressed between patients with either liver or peritoneal metastases. The present findings suggest that the formation of liver metastases might be associated with TLR-associated pathways. In M0, a high expression of FOXP3 + tumor infiltrating lymphocytes (TILs) seemed to prevent at least in part metastases. Thus, these correlative findings lay the cornerstone to further studies elucidating the underlying mechanisms of organotropism of metastases
    corecore